CN Stock MarketDetailed Quotes
301111 Guangdong Lifestrong Pharmacy
- 17.02
- -0.81-4.54%
Market Closed Nov 15 15:00 CST
2.72BMarket Cap159.07P/E (TTM)
17.90High17.02Low59.89KlotVolume17.65Open17.83Pre Close104.55MTurnover8.54%Turnover Ratio81.44P/E (Static)160.00MShares33.3752wk High3.52P/B1.19BFloat Cap11.1052wk Low21.40Limit Up70.14MShs Float66.24Historical High14.26Limit Down4.94%Amplitude11.10Historical Low0.10Dividend TTM17.46Avg Price33.80KlotAsk0.59%Div YieldTTM100Lot Size23.50KlotBid
Guangdong Lifestrong Pharmacy Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 11.02%228.74M | 3.77%152.37M | -10.22%71.2M | 3.20%292.4M | 0.04%206.04M | 9.50%146.84M | 31.78%79.3M | -19.00%283.34M | -18.27%205.95M | -19.76%134.1M |
| Operating revenue | 11.02%228.74M | 3.77%152.37M | -10.22%71.2M | 3.20%292.4M | 0.04%206.04M | 9.50%146.84M | 31.78%79.3M | -19.00%283.34M | -18.27%205.95M | -19.76%134.1M |
| Other operating revenue | ---- | 243.85%380.25K | ---- | 428.47%246.79K | ---- | 266.44%110.59K | ---- | -86.54%46.7K | ---- | -83.83%30.18K |
| Total operating cost | 22.48%229.4M | 15.68%147.39M | -0.79%65.67M | 2.98%266.69M | -0.78%187.3M | 8.93%127.41M | 27.00%66.19M | -9.20%258.98M | -7.50%188.77M | -14.23%116.96M |
| Operating cost | 37.96%92.14M | 23.78%61.61M | -4.72%24.7M | -0.18%91.95M | 1.37%66.79M | 16.53%49.77M | 45.31%25.92M | -14.09%92.11M | -10.89%65.89M | -15.29%42.71M |
| Operating tax surcharges | 5.86%3.2M | 7.62%2.32M | 2.53%1.12M | 4.09%4.29M | 13.21%3.02M | 27.91%2.15M | 40.32%1.1M | -12.88%4.12M | -26.24%2.67M | -28.07%1.68M |
| Operating expense | 5.52%100.8M | 6.03%65.26M | -8.68%30.16M | 0.45%138.45M | -5.90%95.52M | 2.71%61.54M | 18.32%33.03M | -4.31%137.83M | -5.67%101.51M | -15.14%59.92M |
| Administration expense | 61.52%28.42M | 35.64%15.1M | 67.95%7.86M | 43.26%25.86M | 35.28%17.59M | 30.69%11.13M | 33.04%4.68M | -15.44%18.05M | 0.35%13.01M | -6.87%8.52M |
| Financial expense | 15.06%-1.57M | 16.58%-1.12M | 36.88%-448.74K | -0.21%-2.3M | -21.58%-1.85M | -33.90%-1.34M | -8.58%-710.98K | 22.42%-2.29M | 30.86%-1.52M | 33.48%-1M |
| -Interest expense (Financial expense) | -50.51%101.52K | -64.68%23.38K | 1,353.75%139.6K | 1,226.14%368.7K | 720.91%205.15K | 241.14%66.17K | -13.15%9.6K | -50.66%27.8K | -41.36%24.99K | -26.03%19.4K |
| -Interest Income (Financial expense) | 17.45%-1.72M | 17.89%-1.17M | 20.13%-599.67K | -14.73%-2.7M | -30.40%-2.08M | -33.96%-1.42M | -8.05%-750.83K | 25.50%-2.35M | 30.57%-1.59M | 32.03%-1.06M |
| Research and development | 3.15%6.42M | 1.89%4.24M | 4.44%2.26M | -7.84%8.44M | -13.77%6.22M | -19.00%4.16M | -20.16%2.17M | -15.70%9.16M | -11.30%7.21M | -4.07%5.13M |
| Credit Impairment Loss | 36.92%1.31M | 222.17%454.28K | 1,211.93%1.68M | -364,329.67%-2.24M | -56.62%956.74K | 945.39%141.01K | 13.07%-151.11K | 99.91%-614.1 | 490.08%2.21M | 103.62%13.49K |
| Asset Impairment Loss | 479.35%1.74M | 1,412.75%2.33M | 592.26%1.39M | -313.42%-2.6M | 18.90%-458.98K | 151.12%153.82K | -13.13%-283.16K | -98.37%-629.19K | -210.81%-565.96K | -271.32%-300.92K |
| Other net revenue | 1.26%16.57M | 34.00%12.95M | 80.06%7.79M | -17.47%15.47M | -11.98%16.36M | -16.80%9.66M | -33.99%4.32M | 228.44%18.75M | 442.03%18.59M | 541.88%11.61M |
| Fair value change income | -33.34%1.57M | -25.95%1.19M | 11.86%850.05K | -5.12%2.78M | -13.85%2.35M | -11.80%1.6M | -11.90%759.91K | 89.87%2.93M | 175.47%2.73M | 456.59%1.82M |
| Invest income | -7.84%8.38M | -5.41%5.79M | -5.00%2.94M | -0.04%11.9M | -4.73%9.09M | 1.76%6.12M | 20.54%3.1M | 1,257.38%11.9M | 1,844.59%9.54M | 11,503.95%6.01M |
| -Including: Investment income associates | ---50.35K | ---3.56K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | --1.79M | --1.79M | ---- | ---- | ---- | --0 | ---- | -2,843.92%-330.01K | -2,843.92%-330.01K | -2,843.92%-330.01K |
| Other revenue | -59.73%1.78M | -15.00%1.4M | 2.00%916.57K | 15.59%5.63M | -11.68%4.43M | -62.59%1.65M | -74.61%898.63K | 12.95%4.87M | 85.07%5.01M | 132.19%4.4M |
| Operating profit | -54.67%15.91M | -38.36%17.93M | -23.65%13.32M | -4.46%41.18M | -1.86%35.11M | 1.19%29.09M | 19.33%17.44M | -38.65%43.1M | -30.33%35.77M | -11.74%28.75M |
| Add:Non operating Income | 24.98%331.13K | 38.11%291.01K | 130.88%209.35K | -43.86%195.5K | -17.20%264.95K | 22.70%210.71K | 20.26%90.67K | -86.75%348.22K | -87.34%320.01K | -93.16%171.74K |
| Less:Non operating expense | 295.03%1.56M | 309.66%1.41M | -98.32%2.08K | -53.04%4.09M | -74.09%396.11K | 112.45%344.67K | -14.72%123.88K | 41.10%8.7M | 4,602.45%1.53M | 471.33%162.24K |
| Total profit | -58.03%14.68M | -41.95%16.81M | -22.31%13.52M | 7.31%37.29M | 1.19%34.98M | 0.69%28.95M | 19.67%17.41M | -47.92%34.75M | -35.80%34.57M | -17.97%28.76M |
| Less:Income tax cost | -86.23%652.17K | -68.66%1.32M | -20.72%2.05M | 257.23%4.76M | 37.12%4.73M | 27.64%4.21M | 78.77%2.59M | -86.04%1.33M | -54.52%3.45M | -32.39%3.29M |
| Net profit | -53.62%14.03M | -37.41%15.49M | -22.59%11.47M | -2.65%32.53M | -2.80%30.24M | -2.80%24.75M | 13.13%14.82M | -41.56%33.42M | -32.73%31.11M | -15.64%25.46M |
| Net profit from continuing operation | -53.62%14.03M | -37.41%15.49M | -22.59%11.47M | -2.65%32.53M | -2.80%30.24M | -2.80%24.75M | 13.13%14.82M | -41.56%33.42M | -32.73%31.11M | -15.64%25.46M |
| Net income from discontinuing operating | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Less:Minority Profit | 70.71%-72.93K | 795.32%386.96K | -540,323.51%-268.48K | -4,160,171.37%-969.34K | -1,285,554.26%-249.03K | ---55.65K | ---49.68 | ---23.3 | ---19.37 | --0 |
| Net profit of parent company owners | -53.76%14.1M | -39.11%15.1M | -20.78%11.74M | 0.25%33.5M | -2.00%30.49M | -2.58%24.81M | 13.13%14.82M | -41.56%33.42M | -32.73%31.11M | -15.64%25.46M |
| Earning per share | ||||||||||
| Basic earning per share | -53.39%0.0881 | -38.98%0.0944 | -22.22%0.07 | 0.00%0.21 | -2.83%0.189 | -2.77%0.1547 | 12.50%0.09 | -56.25%0.21 | -49.53%0.1945 | -36.74%0.1591 |
| Diluted earning per share | -53.39%0.0881 | -38.98%0.0944 | -22.22%0.07 | 0.00%0.21 | -2.83%0.189 | -2.77%0.1547 | 12.50%0.09 | -56.25%0.21 | -49.53%0.1945 | -36.74%0.1591 |
| Other composite income | ||||||||||
| Total composite income | -53.62%14.03M | -37.41%15.49M | -22.59%11.47M | -2.65%32.53M | -2.80%30.24M | -2.80%24.75M | 13.13%14.82M | -41.56%33.42M | -32.73%31.11M | -15.64%25.46M |
| Total composite income of parent company owners | -53.76%14.1M | -39.11%15.1M | -20.78%11.74M | 0.25%33.5M | -2.00%30.49M | -2.58%24.81M | 13.13%14.82M | -41.56%33.42M | -32.73%31.11M | -15.64%25.46M |
| Total composite income of minority owners | 70.71%-72.93K | 795.32%386.96K | -540,323.51%-268.48K | -4,160,171.37%-969.34K | -1,285,554.26%-249.03K | ---55.65K | ---49.68 | ---23.3 | ---19.37 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data